For Research Purposes Only

Cycle Guide

BPC-157 Cycle Guide

Cycling BPC-157 appropriately maximizes healing potential while managing unknown long-term risks. Cycle length depends on the injury type, severity, and response. This guide covers cycle design from acute injuries to chronic conditions.

Key Points

Acute injuries: 2-4 week cycles
Chronic conditions: 6-8 week cycles
Post-surgery: 4-8 weeks after physician clearance
Rest 2-4 weeks between cycles
Reassess improvement during rest period

Step-by-Step Guide

1

Acute Injury Cycle

For recent injuries (sprains, strains, minor tears): 2-4 weeks at 250-500 mcg/day. Start as soon as possible after injury. Shorter cycles often sufficient for acute recovery.

2

Chronic Injury Cycle

For long-standing conditions (tendinopathy, chronic joint issues): 6-8 weeks at 250-500 mcg/day. Chronic conditions have established pathology requiring longer intervention periods.

3

Post-Surgery Cycle

For surgical recovery support: 4-8 weeks starting 1-2 weeks post-surgery (after physician clearance). Dosing at 500 mcg/day split into morning and evening injections for consistent levels.

4

Rest Period

Take 2-4 weeks off between cycles. This rest period allows assessment of maintained improvement vs regression, and limits continuous peptide exposure.

5

Reassess and Repeat

After the rest period, evaluate if another cycle is warranted. If 80%+ improvement is maintained, no additional cycle needed. If regression occurs, a second cycle may be considered.

Warnings & Precautions

  • !No clinical data establishes optimal cycle length.
  • !Longer is not necessarily better—diminishing returns may apply.
  • !Do not use BPC-157 as a substitute for necessary medical treatment.
  • !Rest periods between cycles are important for assessment.

Frequently Asked Questions

How many BPC-157 cycles can I do?

Most research community protocols suggest 1-3 cycles for a given injury. If no improvement after 2 full cycles, the injury may require different intervention. Indefinite continuous use is not recommended due to lack of long-term safety data.

Can I run BPC-157 continuously?

Not recommended. While no specific toxicity from continuous use has been documented, cycling provides assessment windows and limits exposure to a compound without long-term human safety data. Rest periods also help determine if improvement is sustained.

When should I stop a BPC-157 cycle early?

Stop if: no improvement after 3 weeks, worsening symptoms, unusual side effects (rash, swelling, systemic symptoms), or if the injury clearly requires medical intervention rather than peptide support.

Related Protocols

Disclaimer: Protocol information is for educational purposes only. Not medical advice. Consult healthcare professionals.